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ST239-MRSA-III is probably the oldest truly pandemic MRSA strain, circulating in many
countries since the 1970s. It is still frequently isolated in some parts of the world
although it has been replaced by other MRSA strains in, e.g., most of Europe. Previous
genotyping work (Harris et al., 2010; Castillo-Ramírez et al., 2012) suggested a split in
geographically defined clades. In the present study, a collection of 184 ST239-MRSA-III
isolates, mainly from countries not covered by the previous studies were characterized
using two DNA microarrays (i) targeting an extensive range of typing markers, virulence
and resistance genes and (ii) a SCCmec subtyping array. Thirty additional isolates
underwent whole-genome sequencing (WGS) and, together with publishedWGS data for
215 ST239-MRSA-III isolates, were analyzed using in-silico analysis for comparison with
the microarray data and with special regard to variation within SCCmec elements. This
permitted the assignment of isolates and sequences to 39 different SCCmec III subtypes,
and to three major and several minor clades. One clade, characterized by the integration
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of a transposon into nsaB and by the loss of fnbB and splE was detected among isolates
from Turkey, Romania and other Eastern European countries, Russia, Pakistan, and
(mainly Northern) China. Another clade, harboring sasX/sesI is widespread in South-East
Asia including China/Hong Kong, and surprisingly also in Trinidad & Tobago. A third,
related, but sasX/sesI-negative clade occurs not only in Latin America but also in Russia
and in the Middle East from where it apparently originated and from where it also was
transferred to Ireland. Minor clades exist or existed in Western Europe and Greece, in
Portugal, in Australia and New Zealand as well as in the Middle East. Isolates from
countries where this strain is not epidemic (such as Germany) frequently are associated
with foreign travel and/or hospitalization abroad. The wide dissemination of this strain
and the fact that it was able to cause a hospital-borne pandemic that lasted nearly 50
years emphasizes the need for stringent infection prevention and control and admission
screening.
Keywords: Staphylococcus aureus, MRSA, ST239-MRSA-III, SCCmec element, molecular epidemiology
INTRODUCTION
Staphylococcus aureus is a bacterial species that colonizes the
skin and mucous membranes of a high percentage of the
human population (van Belkum et al., 2009) and several animal
species. It can cause localized infections, such as skin and soft
tissue infections (SSTIs), bone, joint and implant infections
or pneumonia as well as sepsis and toxicoses including toxic
shock syndrome. Resistance toward antibiotics in S. aureus is
a highly relevant issue. Methicillin resistance and resistance to
most beta-lactams is due to the production ofmodified penicillin-
binding proteins encoded by mec genes. The mecA/mecC
genes are located on large, complex and potentially mobile
staphylococcal cassette chromosome (SCCmec) elements (while
mecB was observed on a plasmid; Becker et al., 2018). SCCmec
elements additionally encode regulatory elements and, variably,
genes encoding resistance to other antimicrobials, such as
aminoglycosides, macrolides, tetracyclines, fusidic acid and to
heavy metals (Oliveira et al., 2000; Ito et al., 2001). The
comparatively older SCCmec types I, II, and III are typically
restricted to MRSA strains involved in healthcare-associated
infections (HCA-MRSA).
The HCA-MRSA, sequence type (ST) 239 MRSA, as
designated by multilocus sequence typing (MLST), is of special
interest. As ST240 and ST241 are single locus variants of
ST239 (which differ only by mutations in MLST marker genes
pta or yqil), these STs are here discussed together as clonal
complex (CC) 239. CC239 harboring SCCmec type III have
been designated various names in different geographic regions
including “Wiener Epidemiestamm” (Vienna Epidemic Strain),
the Hungarian Clone, UK-EMRSA−1,−4,−7,−9, or−11, Irish
Phenotype III, Irish AR01,−09,−44, and−23, the Brazilian
Clone, Australian EpidemicMRSA−2 and−3 as well as Canadian
MRSA−3 or−6. CC239-MRSA-III is probably the oldest truly
pandemic MRSA strain. In contrast to other early MRSA strains,
it is still common and widespread, at least in some parts of the
world.
CC239-MRSA-III has been reported in many
European countries including the UK (Edgeworth et al.,
2007), Ireland (Humphreys et al., 1990; Shore et al., 2005),
Spain (Cuevas et al., 2007), Portugal (Smyth et al., 2010),
Italy (Campanile et al., 2009), Malta (Scicluna et al., 2010),
Croatia (Budimir et al., 2009), Germany (Witte et al., 1997;
Albrecht et al., 2011), Austria (Krziwanek et al., 2008), the
Czech Republic (Melter et al., 2003), Hungary (Conceicao
et al., 2007), and Greece (Aires de Sousa et al., 2003a). It is
also frequently observed in Romania (Cirlan et al., 2005; Chen
et al., 2010; Monecke et al., 2014a) and Russia (Afanas’ev et al.,
2010; Baranovich et al., 2010; Yamamoto et al., 2012; Gostev
et al., 2017). CC239-MRSA-III is common to abundant in
Mediterranean and Middle Eastern countries such as Greece
(Aires de Sousa et al., 2003a), Turkey (Alp et al., 2009; Tekeli
et al., 2016), Egypt (El-baz et al., 2017), Morocco, Tunisia,
Algeria (Abdulgader et al., 2015), Iran (Fatholahzadeh et al.,
2009), Saudi Arabia (Cirlan et al., 2005; Monecke et al., 2012c;
Senok et al., 2016), Abu Dhabi (Weber et al., 2010), and Kuwait
(Boswihi et al., 2016). The strain’s presence has been reported
in China (Chen et al., 2014a,b) including Hong Kong (Ip et al.,
2005), Taiwan (Aires de Sousa et al., 2003b; Takano et al., 2007),
Singapore (Hsu et al., 2007), Malaysia (Ghaznavi-Rad et al.,
2010), Mongolia (Orth et al., 2006), Pakistan (Shabir et al., 2010;
Zafar et al., 2011; Arfat, 2013; Jamil et al., 2017), India (D’Souza
et al., 2010; Neetu and Murugan, 2016), South Korea (Cha et al.,
2005; Peck et al., 2009), Laos (Yeap et al., 2017), and Thailand
(Smyth et al., 2010). There are reports from several African
countries including Ghana, Kenya, Niger, Nigeria, Senegal, and
South Africa (Jansen van Rensburg et al., 2011; Abdulgader et al.,
2015). In Eastern Australia and New Zealand it was a common
cause of HCA infection, and it has been reported in association
with large MRSA outbreaks (Coombs et al., 2004; Howden et al.,
2010). In the western hemisphere, CC239-MRSA-III has been
reported from the United States (Schaefler et al., 1981), Brazil
(Vivoni et al., 2006), Paraguay (Mayor et al., 2007), Ecuador
(Zurita et al., 2016), and Trinidad & Tobago where it recently
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was still the predominant MRSA strain (Akpaka et al., 2007;
Monecke et al., 2012b, 2014b).
In terms of genetic structure, ST239 is an interesting clone,
with six of the seven MLST housekeeping genes being identical
to ST8 (Robinson and Enright, 2004a,b). However ST239 as well
as ST240 and ST241 harbor a very different arcC-allele (arcC-
2, rather than arcC-3). The difference in the arcC-allele and the
presence of some other features that differentiate ST239 from
canonical ST8 (including the presence of the collagen adhesion
gene cna, capsule type 5 and RIDOM spa types t030 or t037),
indicate the integration of a large fragment of genomic DNA
of clonal complex (CC) 30 origin into a CC8 chromosome
(Robinson and Enright, 2004b; Holden et al., 2009). The fragment
consists of ∼635,000 base pairs, which is ∼20% of a S. aureus
genome. The mechanism of integration is yet not known.
Another interesting recent observation has been the discovery
of sasX/sesI in CC239-MRSA, a virulence factor thought to have
a key role in nasal colonization, pathogenesis of lung disease,
and abscess formation (Li et al., 2012). The sasX gene is located
on a 127 kb lysogenic prophage phiSPbeta (Li et al., 2012) and
it encodes the surface-anchored protein X, an LPxTG motif
surface-anchored protein, and does not have orthologues in any
of the other sequenced S. aureus genomes. A highly similar gene,
sesI, is present in the S. epidermidis phiSPbeta region and has also
been identified in other coagulase-negative staphylococci such as
S. capitis (GenBank JGYJ) and S. cohnii (GenBank LATU and
LATV).
With the rise of Next Generation Sequencing (NGS)
technologies, Harris and Castillo-Ramírez (Harris et al., 2010;
Castillo-Ramírez et al., 2012) sequenced a large collection of
CC239-MRSA-III from very diverse geographic origins. They
suggested a phylogenetic framework in which isolates of CC239-
MRSA-III clustered in several major “clades” and a couple
of isolated branches. The clades are largely associated with
geographic background and thus were referred to as “European”,
“Latin American”, “Turkish”, and “Asian” clades.
In the present study, a collection of CC239-MRSA-III
isolates was characterized, primarily using previously published
DNA microarray technology targeting typing markers, virulence
and resistance genes and SCCmec subtypes (Monecke et al.,
2008b, 2011, 2016). Published whole-genome sequence data,
in particular those by Harris and Castillo-Ramírez (Harris
et al., 2010; Castillo-Ramírez et al., 2012), were re-analyzed
with regard to the presence or absence of the marker genes as
used experimentally for array hybridization and with regard to
variation within SCCmec elements. A comparison between our
strain collection, mainly from countries that were not covered
by the Harris and Castillo-Ramírez’ work, to published genome
sequences was then performed in order to see if and how they
fit into their proposed phylogenetic framework and to look for
epidemiological connections and suitable marker genes.
MATERIALS AND METHODS
Isolates
In total, 214 clinical or screening isolates were included in the
present study. These isolates originated from hospitals in Ireland,
Germany, Romania, Kuwait, Saudi Arabia, Russia, Pakistan,
China/Hong Kong, Australia, Trinidad&Tobago, and Ecuador
as well as some reference strains (see Supplemental Table 1 and
below). Some of the isolates were a convenience sample from
previous studies (Monecke et al., 2008a, 2011, 2012b,c, 2014a,b,
2016; Albrecht et al., 2011; Boswihi et al., 2016; Senok et al., 2016;
Zurita et al., 2016; Gostev et al., 2017; Jamil et al., 2017). Others
came from ongoing routine diagnostics, outbreak investigations
or typing tasks performed by the authors and have not been
published previously. Only one isolate per patient was included.
Isolates were stored frozen using cryobank tubes (Microbank,
Pro-Lab Diagnostics, Richmond Hill, Canada) at−80◦C. Isolates
were routinely cultured on Columbia blood agar plates, and DNA
preparation was performed as previously described (Monecke
et al., 2008b, 2011).
DNA Microarrays for SCCmec Typing and
Subtyping
Two microarrays were used in the study, and were applied
to 184 of the isolates investigated herein (another 30 were
directly subjected to sequencing; see below). Both arrays have
previously been described including probe and primer sequences,
details of DNA extraction, labeling, amplification, hybridization
protocols as well as data analysis and interpretation. The first
microarray (Monecke et al., 2008b, 2011) detects genes associated
with antibiotic resistance and virulence as well as a multitude
of genes that can be used for typing purposes, such as genes
related to agr or capsule types, set/ssl genes and genes coding for
adhesion factors. In addition to the detection of individual genes,
the array also allows the assignment of isolates to MLST CCs,
to known epidemic strains and to SCCmec types. The second
microarray (Monecke et al., 2016) was designed to subtype
SCCmec elements. It also includes probes for sasX/sesI and for
heavy metal resistance genes. Furthermore, it included a set of
probes termed “SCCterm” followed by a number (see Table 1)
which were designed to recognize intergenic regions alternative
to dcs, between orfX and the first codon on the SCCmec element.
All markers of relevance for SCCmec subtyping are listed in
the Supplemental Table 1. Markers that were detected among
isolates in the present study are listed, and presented in more
detail, in Table 1.
DNA Microarrays for mecA Subtyping
A third assay was used to identify and categorize alleles
and variants of the mecA/C gene as previously described
(Monecke et al., 2012a). While there are a multitude of mecA
variants (also named mecA1) in staphylococcal species other
than S. aureus, only four different mecA/C alleles are of
relevance in S. aureus/MRSA that also differ in amino acid
sequences encoded, i.e., (named with respect to representative
GenBank entries), mecA(CP000046) (as in the CC8-MRSA-I strain
COL), mecA(BA000018) (as in the CC5-MRSA-II strain N315),
mecA(GQ902038) (as in the CC398-MRSA-VT strain UMCG-M4)
andmecC (GenBank NG_047955.1). This array was applied to 30
isolates representing at least one isolate per SCCmec subtype.
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SCCmec Subtypes and Nomenclature
The guidelines of the International Working Group (IWG-
SCC, 2009) were used for the assignment of Roman numerals
to SCCmec types defined by the class of mec gene complex
and type of cassette chromosome recombinase (ccr) genes. As
proposed by Shore and Coleman (2013) we named elements
lacking ccr recombinase genes “pseudoSCCmec elements.”
Composite elements are indicated by listing relevant components
in square brackets. Heavy metal resistance genotypes were
described by adding chemical symbols rather than individual
gene designations e.g., SCC [mec III+Cd/Hg+ccrC]).
Genes aadD, aacA-aphD, ant9, ble, and erm(A) as well as
tet genes were not included in the analysis of the SCCmec III
subtypes. Although these genes may be situated on SCCmec
elements, they also may be found on plasmids or other mobile
genetic elements at various locations [see below for erm(A) and
ant9]. Neither array hybridization nor those NGS technologies
that yield a high number of short contigs can provide reliable
information on the actual localizations of genes, or whether a
plasmid [such as pT181/tet(K)] was free or integrated into the
genome. Consequently, we did not differentiate between SCCmec
III and IIIA (Vandenesch et al., 2003).
In contrast, the mercury resistance operon was included into
the analysis of the SCCmec III subtypes. In CC239 this operon is
part of a composite SCC element, although it can indeed be found
outside of SCC elements (e.g., GenBank: AB179623.1).
All previously sequenced variants were tagged with the
designation of one reference strain in which they have been
sequenced [e.g., the particular variant of SCCmec III from the
strain TW20 is indicated SCC [mec III+Cd/Hg+ccrC] (TW20)].
If we were not able to identify a reference sequence to a given
SCC hybridization pattern, we added “unknown” followed by
the clonal complex(es) and, if there were several similar such
elements, by chronologically assigned numbers [as in SCC [mec
III+Cd+ccrC] (Unknown, ST239−3)].
Sequencing
The genomes of 30 CC239 isolates from Perth/Australia have
been sequenced with Illumina MiSEQ. Sequencing libraries were
prepared with the Nextera kit (Illumina).
Genome Assembly
Sequencing reads of 30 CC239 isolates from Perth/Australia
as well as several read sets downloaded from NCBI Short
read Archive (https://www.ncbi.nlm.nih.gov/sra/; see Table 4
and Supplemental Table 1) were assembled with SPAdes version
3.10.1 (Bankevich et al., 2012). No attempts were made to close
gaps between contigs. Contigs shorter than 500 nt were excluded
from further analysis.
Bioinformatics, Virtual Hybridizations, and
Probe Mapping
To date, several thousand either partially or fully assembled
genomes of S. aureus isolates are available in NCBI GenBank.
Fully assembled genomes comprise one or several sequences
representing complete replicons (the bacterial chromosome and
a variable number of plasmids). Partially assembled sequences
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consist of a set of contigs. The contigs usually end in repeats
and the sequencing reads do not comprise enough information
to link contigs unambiguously. The number of contigs varies
between about 10 and several hundred depending on the
sequencing method, read length, fragment size, coverage depth
and assembling strategy and settings. Partially assembled contigs
are available in NCBI Genbank (http://www.ncbi.nlm.nih.gov/
Traces/wgs/) with special accession numbers assigned which start
with four letters followed by eight digits. The entire set of contigs
is referred to by a accession number which has all digits set to
zero (e.g., AICH00000000.1). For the sake of conciseness, we will
refer to these four-letter codes as an unambiguous identifier of
a specific genome here. To genomes which we have assembled
from raw sequencing reads obtained from the Short Read Archive
(https://www.ncbi.nlm.nih.gov/sra/), we refer to henceforth by
the BioSample accession number (e.g., SAMEA1029552).
A total of 215 genome sequences of CC239 available
in the NCBI database (Table 4 and Supplemental Table 1)
as well as genome sequences of 30 previously unpublished
Australian study isolates were subjected to an in silico
analysis or “virtual hybridization” that allowed a direct
comparison to array hybridization experiments (Tables 2a,b,
3 and Supplemental Table 1). Hybridization patterns were
generated from complete or from partially assembled genomic
sequences.
Probe sequences were mapped on contigs using the program
blastn (Camacho et al., 2009) from the NCBI blast+ suite and
all sites were identified that matched the probe sequences with
less than four mismatches. A signal value between 0 and 1 was
assigned to each probe based on the actual number ofmismatches
derived from, and mimicking the normalized signals from a
real hybridization experiment. A probe without mismatches was
assigned signal intensity of 0.9; with 1 mismatch, a signal of 0.6;
with two mismatches, a signal of 0.3; with three mismatches, a
signal of 0.1. Probes with four—ormore—mismatches were set as
0. These numerical values were then analyzed exactly as data from
real hybridization experiments (Monecke et al., 2008b, 2011).
This approach has been developed and optimized based on
real experiments performed with fully assembled strains (such
as MSSA476, GenBank BX571857; N315, GenBank BA000018;
COL, GenBank CP000046; MRSA252, GenBank BX571856; see
also Monecke et al., 2016). For three strains (ATCC33592, UK-
EMRSA-4, isolate Russia_0085) full genome sequences were
available and we have done real as well as virtual hybridization
experiments that were analyzed in parallel.
Bioinformatics, Analysis of Insertions
Some CC239 genomes comprise a site-specific insertion of a
mobile element into the chromosomale genes nsaB (locus tag
SATW20_27600) or yeeE (locus tag SAT0131_RS10920). Two
query sequences with a size of 80 nt were used to evaluate
assembled genomes for the presents of uninterrupted nasB and
yeeE genes. The two query sequences were choosen to span the
insertion sites (for nasB, FN433596.1[2933542:2933621:r] and for
yeeE, CP002643.1[2151962:2152041:r]). These query sequences
were mapped on all full genome sequences with blastn. If they
did not match for their full length, we assumed that the target
gene was interrupted.
RESULTS
Subtypes of SCCmec III in CC239-MRSA-III
Thirty-nine different variants of SCCmec III or SCCmec III-
derived composite SCC elements or pseudoSCC-elements were
observed in the 425 CC239-MRSA-III isolates and sequences.
A description of these variants is provided in Tables 2a,b. Full
profiles for individual isolates and sequences are shown in
Supplemental Table 1.
Alleles of mecA in CC239-MRSA-III were assigned to two
allelesmatching the CC8-MRSA-I strain COL, CP000046 (among
study isolates tested or sequenced, n = 21) and the CC5-MRSA-
II strain N315, BA000018 (among study isolates, n = 38; one
sequence not unambiguously assigned). When analyzing the
binding sites of the probes used, the difference between the alleles
is an “A” or, respectively, a “G” in position 737 (of the TW20mecA
sequence). Among the sequences and isolates investigated, mecA
alleles largely correlate with the SCCmec subtypes and strains
within CC239, i.e., a single mecA allele was found in association
with each SCCmec subtype. However, there were five exceptions,
i.e., SCCmec subtypes in which both mecA alleles were detected.
This included the more common subtypes and strains (SCC
[mec III+Cd/Hg+ccrC] (TW20), SCC [mec III+Cd/Hg+ccrC]
(Bmb9393), SCC [mec III+Cd] (S2), SCC [mec III+Cd+ccrC]
(XN108), SCC [mec III+Cd] (HSA10/ATCC33592)). This might suggest
that themecA sequence, and its allele assignment, is not a reliable
phylogenetic marker but subject to random mutation (or to
sequencing errors).
All SCCmec III elements from CC239 include a cadmium
resistance operon for which cadD(R35) was used as a marker.
Fifteen SCCmec III elements in CC239 (“Eurasian” strains
with ccrC being located elsewhere not included) were composite
elements that additionally harbor the recombinase gene ccrC.
Sequence analysis identified two different ccrC alleles (Tables 1,
2a,b) that could not be differentiated with the current set of
probes. Genes accompanying ccrC are ccrAA (although the
present allele yields usually only ambiguous signals with the
probes used herein) andD1GU38. Nineteen SCCmec III elements
in CC239 also include themercury resistance operon; this is often
but not always linked to ccrC.
Composite elements that include ACME II (that is, arc genes
present but opp genes absent), an arsenic resistance operon,
genes speG and czrC (zinc/cadmium resistance) were occasionally
found (see Tables 2a,b). No isolates were identified that harbored
composite elements involving ACME I (arc and opp genes),
ACME III (opp genes only) or SCCfus (fusidic acid resistance,
fusC).
The presence of dcs and a SCC terminus sequence or multiple
SCC terminus sequences suggests the presence of composite
elements. Sequence analyses has shown that SCC terminus
sequences are not necessarily situated “terminally” toward orfX
but can be found within a composite element demarking it
components. For example in TW20, SCCterm02 (GenBank
FN433596.1; positions 34,140 to 34,456) is situated toward orfX
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(positions 33,660 to 34,139) while SCCterm01 can be found
between the region including the mercury resistance operon and
the SCCmec element (positions 67,191 to 67,511). As described
below, SCCterm02 can also be associated with integration of a
transposon into the nsaB gene, i.e., at a distant position from
orfX.
Strains and Clades of CC239-MRSA-III
Harris and Castillo-Ramírez (Harris et al., 2010; Castillo-Ramírez
et al., 2012) divided CC239-MRSA-III into several clades based
on SNP analysis. We re-analyzed published sequences from this
project, other previously published sequences as well as our own
sequences and array hybridization patterns regarding presence of
SCCmec III subtypes (see above), the gene sasX/sesI (see below),
the enterotoxin genes sek and seq (representative for S. aureus
pathogenicity island 3), certain resistance markers and regarding
other conspicuous features such as spa types or deletions of
individual genes.
Individual results as well as clade/strain assignments for each
isolate and sequence are listed in the Supplemental Table 1. A
list of strains and clades as well as of their genotypic features
is provided in Table 3. Strain definitions are mainly based on
SCCmec subtypes plus other notable features.
The “Eurasian Clade” and the Insertion into the nsaB
Gene
Harris and Castillo-Ramírez describe a distinct and rather
homogenous “Turkish Clade” (Harris et al., 2010; Castillo-
Ramírez et al., 2012). We found that this clade was not restricted
to Turkey. It also included isolates and sequences (including
T0131, CN79, 16K, 3HK and others) that originate from Eastern
Europe and the Balkans, Russia, Pakistan as well as from China
(mainly Northern China, but also Hong Kong). Thus we suggest
renaming this clade “Eurasian Clade.”
Isolates and sequences assigned to this clade are characterized
by the presence of mecA(BA000018) and dcs. Harris’ strains TUR1
and TUR9 differ in this regard being an intermediate to the
“European Clade” or a product of a horizontal gene transfer of
another variant of a SCCmec III element.
Furthermore, “Eurasian Clade” strains are characterized
by integration of a IS431 based transposon—carrying several
genes that appear to origin from the SCCmec III element—
into the nsaB gene which is located 140,000 nt away
from the SCC element (T0131, GenBank CP002643: position
2,779,896 to 2,803,726). This transposon consists of ccrC, ccrAA,
SCCterm02 and additional genes such as erm(A), ant9, hsdR2-
WIS, D1GU60, A9UFT0, Q93IA1, A5INT3, Q9KX75, Q0P7G0,
Q93IE0, Q3T2M7, Q4LAG3, D2N370, D1GU38, Q2FKL3,
transposase genes and IS431 sequences as well as aacA-aphD
(absent from T0131, but present in 16K; Yamamoto et al., 2012).
This disruption of the nsaB gene was described first in isolates
from Romania (Chen et al., 2010) and Russia (Yamamoto et al.,
2012) but it can be detected in all “Eurasian Clade” sequences. A
insertion into nsaB is also present in TUR1, SAMEA1029552 and
TUR9, SAMEA985415 but due to fragmentation of the sequences
into a high number of contigs, the gene content of their insertion
cannot be reliably determined.
All other sequences and clades of CC239-MRSA-III present
with an un-truncated, wildtype nsaB gene. This includes, despite
their similarity to the “Eurasian Clade”, JKD6008 and related
strains from Australia/New Zealand (see below). However,
erm(A) and ant9 are not restricted to the insertion into nsaB.
These two genes can frequently be found in CC239-MRSA
strains without the nsaB insertion, where they are present
in different localizations. In the previously published genome
sequence Bmb9393, a transposon carrying these two genes
disrupts radC (SABB_05268) while in TW20, this transposon is
present twice, once integrated into radC and once co-localized
with the SCCmec III element. In JKD6008, there are also two
copies of this transposon, one within radC (SAA6008_01621) and
one disrupting ywqG (SAA6008_00825). Therefore the detection
of erm(A) and ant9 cannot be used as a surrogate marker for
the identification of the “Eurasian Clade” but the insertion into
nsaB can.
Other features of the “Eurasian Clade” include a
predominance of RIDOM spa type t030 (with all isolates
previously assigned to spa type t030 belonging to this clade;
Gostev et al., 2017) or t632 (Moscow and Saint Petersburg), the
uniform absence of the mercury resistance operon, the adhesion
factor gene fnbB and the protease gene splE while splA and splB
are present.
The “European Clade”
The basal “European Clade” (Harris et al., 2010) consists
of isolates and sequences that share the SCC [mec
III+Cd/Hg+ccrC] (SK1585) element and variants thereof
from which some genes are fully (mvaS) or partially (mecR1)
deleted. This particular SCCmec element is a composite SCCmec
III/heavy metal resistance element that was first observed in a
strain isolated in Australia as early as in 1973 (see Nimmo et al.,
2015 and section Discussions).
The “European Clade” includes a cluster of homogenous
sequences and isolates from, or with epidemiological connection
to, Greece. These include Harris’ Greek sequences (Harris et al.,
2010), isolates from Saxony/Germany epidemiologically linked
to Greece (see below and Albrecht et al., 2011) and the Greek
reference strain from the Harmony collection (Greece 1_3680).
It also includes two isolates from Morocco.
Some “European Clade” strains have a characteristic deletion
of 166 nt (in 85/2082, GenBank AB037671.1; corresponding the
region in TW20 of FN433596.1 [79030 to 79195]) in the mecR1
gene that results in the paradoxical observation that the probe
associated with mecR1 yields a signal while the one for 1mecR1
does not. These include genome sequences from Australia and
the US (ANS46, LHH1, BK2421) as well as epidemic strains
British UK-MRSA-01 and Irish AR01.
The “South-East Asian Clade” and the sasX/sesI
Gene
The sequences assigned by Harris and Castillo-Ramírez (Harris
et al., 2010; Castillo-Ramírez et al., 2012) to the (South-
East) “Asian Clade” all contain the sasX/sesI gene which
was absent from all sequences not assigned to this clade.
Consequently, sasX/sesI was used in the present study as an
Frontiers in Microbiology | www.frontiersin.org 14 July 2018 | Volume 9 | Article 1436
Monecke et al. Molecular Typing of ST239-MRSA-III
Ta
b
le
3
|
C
la
d
e
s
a
n
d
S
tr
a
in
s
a
n
d
th
e
ir
g
e
n
o
ty
p
ic
c
h
a
ra
c
te
riz
a
tio
n
,
a
s
id
e
n
tifi
e
d
in
th
is
st
u
d
y
o
r
w
h
e
n
a
n
a
ly
zi
n
g
p
u
b
lis
h
e
d
g
e
n
o
m
e
se
q
u
e
n
c
e
s.
C
la
d
e
S
tr
a
in
/i
s
o
la
te
n
a
m
e
,
re
fe
re
n
c
e
s
tr
a
in
o
r
d
e
s
c
ri
p
ti
o
n
R
e
fe
re
n
c
e
s
e
q
u
e
n
c
e
P
S
S
I
S
C
C
m
e
c
e
le
m
e
n
t
cadX
blaZ+R+I
erm(A)
erm(C)
aacA-aphD
aadD
aadE
ant9
aphA3+sat
ble
dfrA
dfrG
mupA
tet(K)
tet(M)
cat
qacA
qacC
sek+seq
sesX/sesI
H
lb
-
in
te
g
ra
ti
n
g
p
h
a
g
e
O
th
e
r
n
o
ta
b
le
fe
a
tu
re
s
E
u
ra
s
ia
n
T
U
R
1
S
A
M
E
A
1
0
2
9
5
5
2
2
0
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(T
U
R
1
)
s
e
a
+
s
a
k+
s
c
n
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
T
0
1
3
1
C
P
0
0
2
6
4
3
.1
4
1
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(T
0
1
3
1
)
s
e
a
+
s
a
k+
s
c
n
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
a
rs
C
-S
C
C
-
p
o
s
.
s
tr
a
in
s
fr
o
m
R
o
m
a
n
ia
–
0
2
S
C
C
[m
e
c
III
+
A
s/
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
1
)
S
C
C
[m
e
c
III
+
A
s/
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
2
)
s
e
a
+
s
a
k+
s
c
n
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
1
6
K
/C
N
7
9
G
e
n
B
a
n
k
A
N
C
J,
B
A
B
Z
6
0
2
8
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(C
N
7
9
)
s
e
a
+
s
a
k+
s
c
n
(c
o
m
m
.)
;
s
e
a
(N
3
1
5
)+
s
a
k
+
c
h
p
+
s
c
n
(r
a
re
,
S
a
in
t
P
e
te
rs
b
u
rg
o
n
ly
);
n
o
n
e
(r
a
re
)
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
IU
1
7
G
e
n
B
a
n
k
C
T
X
B
2
0
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(IU
1
7
)
s
e
a
+
s
a
k+
s
c
n
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
S
p
o
ra
d
ic
s
tr
a
in
s
fr
o
m
S
a
x
o
n
y
–
0
2
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
2
)
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
3
)
s
e
a
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t
K
u
w
a
it
i
A
C
M
E
II
-p
o
s
.
S
tr
a
in
–
0
2
S
C
C
[m
e
c
III
+
A
C
M
E
II+
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
)
s
e
a
s
p
lE
a
n
d
fn
b
B
a
b
s
e
n
t.
A
C
M
E
II
p
re
se
n
t
E
u
ro
p
e
a
n
“G
re
e
k
E
p
id
e
m
ic
S
tr
a
in
”
S
A
M
E
A
1
0
2
9
5
1
3
,
S
A
M
E
A
1
0
2
9
5
3
2
3
7
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(S
K
1
5
8
5
)
s
e
a
+
s
a
k+
s
c
n
fn
b
A
c
o
m
m
o
n
ly
a
b
se
n
t
Ir
is
h
A
R
0
1
/U
K
E
M
R
S
A
-0
1
S
A
M
E
A
1
0
2
9
5
3
7
,
A
B
0
3
7
6
7
1
.1
(S
C
C
m
e
c
o
n
ly
)
2
5
S
C
C
[m
e
c
III
(D
e
lta
m
e
c
R
1
-)
+
C
d
/H
g
+
c
c
rC
]
(8
5
/
2
0
8
2
)
s
e
a
+
s
a
k+
s
c
n
b
b
p
a
b
se
n
t
fr
o
m
U
K
1
a
n
d
Ir
is
h
is
o
la
te
s
B
K
2
4
2
1
S
A
M
E
A
1
0
2
9
5
1
0
1
0
S
C
C
[m
e
c
III
(D
e
lta
m
e
c
R
1
-)
+
C
d
/H
g
+
c
c
rC
]
(B
K
2
4
2
1
)
s
e
a
+
s
a
k+
s
c
n
-
A
u
s
tr
a
li
a
n
/N
Z
J
K
D
6
0
0
8
C
P
0
0
2
1
2
0
.1
2
2
9
S
C
C
[m
e
c
III
+
C
d
]
(J
K
D
6
0
0
8
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r.
);
o
r
n
o
n
e
s
p
lA
+
B
+
E
va
ria
b
le
A
C
M
E
-p
o
s
.
v
a
ri
a
n
t
o
f
J
K
D
6
0
0
8
–
0
3
S
C
C
[m
e
c
III
+
A
C
M
E
II+
C
d
](U
n
kn
o
w
n
,S
T
2
3
9
−
1
)
s
e
a
+
s
a
k+
s
c
n
A
C
M
E
II
p
re
se
n
t
S
o
u
th
-E
a
s
t
A
s
ia
n
T
W
2
0
(I
ri
s
h
A
R
4
4
)
G
e
n
B
a
n
k
F
N
4
3
3
5
9
6
.1
3
7
3
6
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(T
W
2
0
)
s
e
a
+
s
a
k+
s
c
n
(c
o
m
m
.)
;
s
a
k+
c
h
p
+
s
c
n
(v
a
r.
);
s
a
k+
s
c
n
(r
a
re
)
n
o
n
e
(r
a
re
)
s
p
lE
a
b
se
n
t
fr
o
m
M
id
e
a
st
e
rn
is
o
la
te
s
a
n
d
S
yr
ia
n
se
q
u
e
n
c
e
M
5
9
2
,
S
A
M
E
A
8
6
2
5
5
0 (C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 15 July 2018 | Volume 9 | Article 1436
Monecke et al. Molecular Typing of ST239-MRSA-III
Ta
b
le
3
|
C
o
n
tin
u
e
d
C
la
d
e
S
tr
a
in
/i
s
o
la
te
n
a
m
e
,
re
fe
re
n
c
e
s
tr
a
in
o
r
d
e
s
c
ri
p
ti
o
n
R
e
fe
re
n
c
e
s
e
q
u
e
n
c
e
P
S
S
I
S
C
C
m
e
c
e
le
m
e
n
t
cadX
blaZ+R+I
erm(A)
erm(C)
aacA-aphD
aadD
aadE
ant9
aphA3+sat
ble
dfrA
dfrG
mupA
tet(K)
tet(M)
cat
qacA
qacC
sek+seq
sesX/sesI
H
lb
-
in
te
g
ra
ti
n
g
p
h
a
g
e
O
th
e
r
n
o
ta
b
le
fe
a
tu
re
s
S
tr
a
in
w
it
h
a
T
W
2
0
-d
e
ri
v
e
d
p
s
e
u
d
o
e
le
m
e
n
tG
e
n
B
a
n
k
JB
M
O
1
1
P
se
u
d
o
S
C
C
m
e
c
[c
la
ss
A
+
C
d
/H
g
+
c
c
rC
]
(U
C
IM
6
0
1
5
)
s
e
a
+
s
a
k+
s
c
n
o
r
n
o
n
e
–
Z
1
7
2
G
e
n
B
a
n
k
C
P
0
0
6
8
3
8
.1
1
1
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(Z
1
7
2
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r.
);
o
r
n
o
n
e
s
p
lE
va
ria
b
le
m
v
a
S
-
d
e
le
ti
o
n
v
a
ri
a
n
t
o
f
Z
1
7
2
1
0
1
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(U
n
kn
o
w
n
S
T
2
3
9
)
s
e
a
+
s
a
k+
s
c
n
–
X
N
1
0
8
G
e
n
B
a
n
k
C
P
0
0
7
4
4
7
.1
4
9
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(X
N
1
0
8
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r.
);
s
a
k+
c
h
p
+
s
c
n
(r
a
re
);
n
o
n
e
(r
a
re
)
–
S
8
5
S
A
M
E
A
1
0
2
9
5
2
9
2
3
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(S
8
5
)
s
a
k+
c
h
p
+
s
c
n
–
P
P
U
K
M
-7
7
5
-
2
0
0
9
-
G
e
n
B
a
n
k
A
M
R
E
1
1
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(P
P
U
K
M
−
7
7
5
−
2
0
0
9
)
s
e
a
+
s
a
k+
s
c
n
o
r
s
a
k+
c
h
p
+
s
c
n
–
s
a
s
X
-p
o
s
.
m
e
r+
/c
c
rC
n
e
g
.
is
o
la
te
s
fr
o
m
K
u
w
a
it
–
0
2
S
C
C
[m
e
c
III
+
H
g
]
(U
n
kn
o
w
n
,
S
T
2
3
9
)
s
e
a
+
s
a
k+
s
c
n
o
r
n
o
n
e
–
s
a
s
X
-p
o
s
.
s
tr
a
in
w
it
h
a
B
m
b
9
3
9
3
-l
ik
e
S
C
C
e
le
m
e
n
t
G
e
n
B
a
n
k
C
P
0
1
3
9
5
7
.1
1
8
1
7
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(B
m
b
9
3
9
3
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r.
);
s
a
k+
c
h
p
+
s
c
n
(r
a
re
);
s
a
k+
s
c
n
(r
a
re
)
n
o
n
e
(r
a
re
)
–
M
4
1
8
G
e
n
B
a
n
k
C
T
X
S
1
0
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(M
4
1
8
/
U
K
−
9
)
s
e
a
+
s
a
k+
s
c
n
–
N
M
R
0
8
G
e
n
B
a
n
k
C
P
0
2
3
5
6
0
.1
2
1
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(N
M
R
0
8
)
s
e
a
+
s
a
k+
s
c
n
–
s
a
s
X
-p
o
s
.
A
C
M
E
-p
o
s
.
s
tr
a
in
–
0
1
S
C
C
[m
e
c
III
+
A
C
M
E
II+
C
d
/H
g
]
(U
n
kn
o
w
n
,
S
T
2
3
9
)
s
e
a
+
s
a
k+
s
c
n
A
C
M
E
II
p
re
se
n
t
s
a
s
X
-
p
o
s
/c
z
rC
-
p
o
s
.
s
tr
a
in
s
–
0
5
S
C
C
[m
e
c
III
+
sp
e
G
+
C
d
/H
g
/c
zr
C
+
c
c
rA
B
4
C
]
(U
n
kn
o
w
n
,
S
T
2
3
9
)
S
C
C
[m
e
c
III
+
s
p
e
G
+
C
d
/c
zr
C
+
c
c
rA
B
4
C
]
(U
n
kn
o
w
n
,
S
T
2
3
9
)
n
o
n
e
–
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 16 July 2018 | Volume 9 | Article 1436
Monecke et al. Molecular Typing of ST239-MRSA-III
Ta
b
le
3
|
C
o
n
tin
u
e
d
C
la
d
e
S
tr
a
in
/i
s
o
la
te
n
a
m
e
,
re
fe
re
n
c
e
s
tr
a
in
o
r
d
e
s
c
ri
p
ti
o
n
R
e
fe
re
n
c
e
s
e
q
u
e
n
c
e
P
S
S
I
S
C
C
m
e
c
e
le
m
e
n
t
cadX
blaZ+R+I
erm(A)
erm(C)
aacA-aphD
aadD
aadE
ant9
aphA3+sat
ble
dfrA
dfrG
mupA
tet(K)
tet(M)
cat
qacA
qacC
sek+seq
sesX/sesI
H
lb
-
in
te
g
ra
ti
n
g
p
h
a
g
e
O
th
e
r
n
o
ta
b
le
fe
a
tu
re
s
s
a
s
X
-p
o
s
.
s
p
o
ra
d
ic
s
tr
a
in
s
fr
o
m
K
u
w
a
it
a
n
d
H
o
n
g
K
o
n
g
0
5
S
C
C
[m
e
c
III
+
C
d
/H
g
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
1
)
S
C
C
[m
e
c
III
+
C
d
/H
g
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
2
)
s
e
a
+
s
a
k+
c
h
p
+
s
c
n
s
e
a
+
s
a
k+
s
c
n
o
r
n
o
n
e
s
s
l0
1
to
s
s
l0
5
a
b
se
n
t
in
H
K
is
o
la
te
P
3
2
G
e
n
B
a
n
k
C
T
X
V
1
0
S
C
C
[m
e
c
III
+
C
d
]
(H
S
A
1
0
/
A
T
C
C
3
3
5
9
2
)
n
o
n
e
s
d
rD
a
b
se
n
t
A
C
M
E
-p
o
s
.
s
tr
a
in
s
im
il
a
r
to
P
3
2
1
S
C
C
[m
e
c
III
+
A
C
M
E
II+
C
d
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
2
)
s
a
k+
s
c
n
–
h
la
-n
e
g
a
ti
v
e
S
o
u
th
-E
a
s
t
A
s
ia
n
D
E
N
9
0
7
S
A
M
E
A
1
0
2
9
5
4
8
1
0
S
C
C
[m
e
c
III
+
C
d
/H
g
]
(D
E
N
9
0
7
)
s
e
a
+
s
a
k+
s
c
n
h
la
a
b
s
e
n
t
S
2
/M
1
1
6
S
A
M
E
A
1
0
2
9
5
6
3
G
e
n
B
a
n
k
C
T
X
Q
1
2
0
S
C
C
[m
e
c
III
+
C
d
]
(S
2
)
s
e
a
+
s
a
k+
s
c
n
h
la
a
b
s
e
n
t
P
o
rt
u
g
u
e
s
e
P
o
rt
u
g
u
e
s
e
&
A
T
C
C
3
3
5
9
2
s
tr
a
in
G
e
n
B
a
n
k
JX
Z
H
8
5
S
C
C
[m
e
c
III
+
C
d
]
(H
S
A
1
0
/
A
T
C
C
3
3
5
9
2
)
s
e
a
+
s
a
k+
s
c
n
(r
a
re
);
s
a
k+
c
h
p
+
s
c
n
(r
a
re
);
s
a
k+
s
c
n
(v
a
r)
o
r
n
o
n
e
(v
a
r)
s
p
l
g
e
n
e
s
va
ria
b
ly
a
b
se
n
t,
b
b
p
a
n
d
s
d
rD
sp
o
ra
d
ic
a
lly
a
b
se
n
t
S
o
u
th
A
m
e
ri
c
a
n
/
M
id
d
le
E
a
s
te
rn
B
m
b
9
3
9
3
/U
K
E
M
R
S
A
-1
1
G
e
n
B
a
n
k
C
P
0
0
5
2
8
8
.1
3
4
4
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(B
m
b
9
3
9
3
)
B
R
A
2
-S
tr
a
in
S
A
M
E
A
1
0
2
9
5
1
4
6
0
S
C
C
[m
e
c
III
+
C
d
/H
g
]
(B
R
A
2
)
s
a
k+
c
h
p
+
s
c
n
(c
o
m
m
.)
o
r
n
o
n
e
S
tr
a
in
w
ith
a
B
R
A
2
-d
e
riv
e
d
p
se
u
d
o
e
le
m
e
n
t
G
e
n
B
a
n
k
M
IH
O
1
0
P
se
u
d
o
S
C
C
m
e
c
[c
la
ss
A
+
C
d
/H
g
]
(U
P
1
0
7
3
)
s
a
k+
c
h
p
+
s
c
n
M
R
S
A
_P
R
1
G
e
n
B
a
n
k
A
N
P
O
2
3
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(X
N
1
0
8
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r.
);
s
a
k+
c
h
p
+
s
c
n
(v
a
r.
)
b
b
p
a
b
se
n
t
in
M
R
S
A
_P
R
1
b
u
t
p
re
se
n
t
in
o
th
e
rs
s
a
s
X
-
n
e
g
a
ti
v
e
s
tr
a
in
w
it
h
a
S
8
5
-l
ik
e
S
C
C
e
le
m
e
n
t
–
0
2
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(S
8
5
)
s
a
k+
c
h
p
+
s
c
n
s
p
lE
a
b
se
n
t
U
K
E
M
R
S
A
-0
9
–
0
1
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(U
K
−
E
M
R
S
A
−
9
)
s
a
k+
s
c
n
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 17 July 2018 | Volume 9 | Article 1436
Monecke et al. Molecular Typing of ST239-MRSA-III
Ta
b
le
3
|
C
o
n
tin
u
e
d
C
la
d
e
S
tr
a
in
/i
s
o
la
te
n
a
m
e
,
re
fe
re
n
c
e
s
tr
a
in
o
r
d
e
s
c
ri
p
ti
o
n
R
e
fe
re
n
c
e
s
e
q
u
e
n
c
e
P
S
S
I
S
C
C
m
e
c
e
le
m
e
n
t
cadX
blaZ+R+I
erm(A)
erm(C)
aacA-aphD
aadD
aadE
ant9
aphA3+sat
ble
dfrA
dfrG
mupA
tet(K)
tet(M)
cat
qacA
qacC
sek+seq
sesX/sesI
H
lb
-
in
te
g
ra
ti
n
g
p
h
a
g
e
O
th
e
r
n
o
ta
b
le
fe
a
tu
re
s
Is
o
la
te
fr
o
m
To
g
o
–
0
1
S
C
C
[m
e
c
III
+
C
d
/H
g
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
3
)
s
e
a
+
s
a
k+
s
c
n
Ir
is
h
A
R
0
9
/
U
K
E
M
R
S
A
-0
4
a
n
d
−
0
7
G
e
n
B
a
n
k
A
E
E
K
7
2
0
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(T
W
2
0
)
s
e
a
+
s
a
k+
s
c
n
(v
a
r)
;
s
a
k+
c
h
p
+
s
c
n
(v
a
r.
)
s
e
a
(N
3
1
5
)+
s
a
k+
c
h
p
+
s
c
n
(r
a
re
,
A
lg
e
ria
o
n
ly
);
n
o
n
e
(r
a
re
)
s
p
lE
va
ria
b
ly
a
b
se
n
t,
s
s
l0
1
to
s
s
l0
6
a
b
se
n
t
in
H
K
is
o
la
te
s
Ir
is
h
A
R
2
3
–
0
1
S
C
C
[m
e
c
III
+
H
g
+
c
c
rC
]
(A
R
2
3
)
s
e
a
+
s
a
k+
s
c
n
R
e
la
te
d
to
S
o
u
th
A
m
e
ri
c
a
n
/
M
id
d
le
E
a
s
te
rn
K
ra
s
n
o
y
a
rs
k
ts
t1
+
S
tr
a
in
G
e
n
B
a
n
k
B
B
K
C
1
4
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(B
m
b
9
3
9
3
)
w
ith
m
e
c
A
(B
A
0
0
0
0
1
8
)
s
a
k+
s
c
n
ts
t1
p
o
s
it
iv
e
U
R
U
1
1
0
S
A
M
E
A
1
0
2
9
5
4
0
1
0
S
C
C
[m
e
c
III
+
C
d
/H
g
+
c
c
rC
]
(B
m
b
9
3
9
3
)
w
ith
m
e
c
A
(B
A
0
0
0
0
1
8
)
s
e
a
+
s
a
k+
s
c
n
D
S
_0
1
4
G
e
n
B
a
n
k
F
Q
P
U
1
0
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(X
N
1
0
8
)
w
ith
m
e
c
A
(B
A
0
0
0
0
1
8
)
s
a
k+
c
h
p
+
s
c
n
U
n
a
s
s
ig
n
e
d
U
n
a
s
s
ig
n
e
d
M
id
d
le
E
a
s
te
rn
S
tr
a
in
–
0
4
S
C
C
[m
e
c
III
+
C
d
+
c
c
rC
]
(U
n
kn
o
w
n
,
S
T
2
3
9
−
1
)
s
e
a
+
s
a
k+
s
c
n
h
la
a
b
s
e
n
t
B
o
ld
fo
n
t
o
f
e
le
m
e
n
t
d
e
s
ig
n
a
ti
o
n
s
in
d
ic
a
te
s
th
o
s
e
e
le
m
e
n
ts
th
a
t
w
e
re
fo
u
n
d
in
s
tu
d
y
is
o
la
te
s
.
C
o
lu
m
n
“P
S
”
in
d
ic
a
te
s
th
e
n
u
m
b
e
r
o
f
(n
o
n
-d
u
p
lic
a
te
)
p
re
vi
o
u
s
ly
p
u
b
lis
h
e
d
s
e
q
u
e
n
c
e
s
a
n
a
ly
ze
d
,
th
e
C
o
lu
m
n
“S
I”
in
d
ic
a
te
s
th
e
n
u
m
b
e
r
o
f
s
tu
d
y
is
o
la
te
s
.
S
ym
b
o
ls
/a
b
b
re
vi
a
ti
o
n
s
fo
r
fr
e
q
u
e
n
c
ie
s
o
f
va
ri
a
b
le
g
e
n
e
s
:
,
a
lw
a
ys
a
b
s
e
n
t;
,
ra
re
,
i.e
.,
p
re
s
e
n
t
in
<
2
0
%
o
f
a
n
a
ly
ze
d
s
e
q
u
e
n
c
e
s
a
n
d
/o
r
c
h
a
ra
c
te
ri
ze
d
is
o
la
te
s
;
,
va
ri
a
b
le
,
i.e
.,
p
re
s
e
n
t
in
2
0
–
8
0
%
;
,
c
o
m
m
o
n
,
i.e
.,
p
re
s
e
n
t
in
m
o
re
th
a
n
8
0
%
;
,
a
lw
a
ys
p
re
s
e
n
t.
Frontiers in Microbiology | www.frontiersin.org 18 July 2018 | Volume 9 | Article 1436
Monecke et al. Molecular Typing of ST239-MRSA-III
identifying marker for this clade. In all sasX/sesI-positive CC239
sequences analyzed, the sasX/sesI prophage is localized in the
same position within the genome, splitting yeeE (FN433596.1;
positions 2180899 to 2181684 downstream of the phage insertion,
and 2308889 to 2309177 upstream). This, and the observation
that the entire cluster appeared in previous sequencing studies
to be monophyletic (Harris et al., 2010; Castillo-Ramírez
et al., 2012) suggest that the “South-East Asian Clade” is one
distinct lineage resulting from one single acquisition of the
sasX/sesI prophage. Differences affectingmobile genetic elements
(including SCCmec) and the presence of the alpha haemolysin
gene hla (which is absent from several sequences, mainly from the
Middle East and Thailand) could then be considered secondary.
SCCmec elements in the “South-East Asian Clade” are
complex composite elements consisting of SCCmec III [usually,
but not always, with mecA(CP000046)], ccrC, cadD as well as
of SCCterm01 and/or 02 sequences. The mercury resistance
operon is nearly always present, and the few exceptions might
be regarded as secondary deletions.
Isolates and sequences originate from South-East Asia,
including Hong Kong and Southern China, India, Australia,
the Middle East, Western Europe and, surprisingly, Trinidad &
Tobago. The clade comprises also TW20 (NCTC13626), AUS-
EMRSA-3 and Harmony Collection Finland E24_98541.
The “South American/Middle Eastern Clade”
Furthermore, there is a large clade encompassing a wide
variety of isolates and sequences and that show identical or
very similar SCCmec types as the “South-East Asian Clade”
(Table 2b) but that are sasX/sesI-negative. This includes the
“South American Clade” sequences (Harris et al., 2010; Castillo-
Ramírez et al., 2012) with three different SCCmec subtypes
(SCC [mec III+Cd/Hg+ccrC] (Bmb9393), SCC [mec III+Cd/Hg]
(BRA2) without ccrC and associated genes and pseudoSCCmec
[class A+Cd/Hg] (UP1073) without any ccr genes). However, there
are also isolates and sequences that originate mainly from the
Middle East, but also from Europe and Russia, and that have
identical or similar SCCmec types. Hence, we referred to this
clade herein as the “South American/Middle Eastern Clade.”
This clade includes Bmb9393, ATCC BAA-39, NCTC13131, UK-
EMRSA-4, UK-EMRSA-7, UK-EMRSA-9 and UK-EMRSA-11,
Irish AR09 and AR23 and the unique tst1-positive strain from
Krasnoyarsk, Russia.
Other Clades
Furthermore, there are additional geographically restricted clades
and strains that do not fit into the larger clades as defined by
Harris and Castillo-Ramírez (Harris et al., 2010; Castillo-Ramírez
et al., 2012).
One group of sequences and isolates could be named the
“Australian/New Zealand Clade” consisting of a number of
isolates from Australia and New Zealand with JKD6009 and
JKD6008 being representative genome sequences. Isolates lacked
sasX/sesI, themer operon and ccrC. They carriedmecA(BA000018).
Similar to the “Eurasian Clade” strains, they harbored dcs but they
differed in the absence of the secondary SCC-like gene cluster
inserted into nsaB.
Another clade comprises a very homogenous cluster of
Portuguese genome sequences from Harris’ work and a similar
strain, ATCC 33592, from New York City. The isolates and
sequences lack sasX/sesI, dcs, ccrC, the mercury resistance operon
and an integration into nsaB, but harbor SCCterm01.
We also observed a cluster of isolates from the Middle East,
Libya and Russia that did not match any published sequences.
These isolates carried mecA(BA000018) and ccrC but lacked the
mercury resistance operon, the nsaB integration, sasX/sesI and
hla.
Isolates by Geographic Origin
An overview on geographic origins by clade and strain is
provided in Table 4. In the following paragraph a short summary
by countries and different sampling sites is given.
African Countries
Although CC239-MRSA-III has been observed in several African
contries (Jansen van Rensburg et al., 2011; Abdulgader et al.,
2015), there are insufficient data on epidemiological trends or
molecular epidemiology.
Six isolates from five different African countries were
included in the study. One isolate from Algeria was a
“South American/Middle Eastern Clade” strain carrying SCCmec
III+Cd/Hg+ccrC (TW20), and was identical to Irish AR09. One
isolate from a Libyan patient (who was brought to North-Eastern
Germany for humanitarian aid) belonged to the unassigned
“Middle Eastern” strain. Two isolates from Morocco matched
the “European Clade”, being most similar to the “Greek Strain”
but differed from the other isolates in the presence of sek/seq
and the absence of cadX, erm(C) and tet(M). One isolate from
Togo matched the “South American/Middle Eastern Clade”
but harbored an unique SCCmec subtype [designated SCCmec
III+Cd/Hg (Unknown, ST239−3) inTable 2b]. This isolatemight be a
derivative of UK EMRSA-9 that has lost ccrC and accompanying
genes. One isolate from Uganda (Monecke et al., 2013a) was
sasX/sesI-positive and belonged to the “South-East Asian Clade.”
Australia
CC239-MRSA-III have been present in Australia for decades
(Dubin et al., 1991; Coombs et al., 2004; Howden et al., 2010;
Nimmo et al., 2015) with distinct variants (Aus-2 EMRSA
and Aus-3 EMRSA) being distinguished based on mercury
susceptibility or resistance, respectively (Coombs et al., 2006).
Eighteen Australian isolates were genotyped by microarray,
and Ilumina NGS sequences of an additional 30 isolates were
analyzed. The majority of isolates (n = 31) were very similar
to JKD6008, GenBank CP002120.1, and JKD6009, GenBank
ABSA from New Zealand and Australia, respectively, forming a
distinct “Australian/New Zealand (NZ) Clade” (correlating to the
mercury susceptible “Aus-2 EMRSA”). Three isolates harbored an
ACME II cluster as well as Q9S0M4 and yielded additional signals
for SCCterm03 and 05. The isolates might be regarded as direct
derivatives of the JKD6008/6009 strain.
Thirteen isolates belonged to the “South-East Asian Clade”
possibly indicating foreign importation which, given the
geographic links between Australia and Asia, seems likely.
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Interestingly, two of these isolates also harbored the ACME
II cluster. One isolate matched the Middle Eastern/Irish AR09
strain. One previously published Australian CC239 genome
sequence, ANS46 (SAMEA1029537) belonged to the “European
Clade,” UK-01/AR01.
The SCCmec element of the “Greek Strain,” SCC [mec
III+Cd/Hg+ccrC] (SK1585), was also previously observed in
Australia, in the chimeric strain, ST2249-MRSA-III, SK1585
(GenBank AYLT and KL662257.1) (Nimmo et al., 2015).
China/Hong Kong
CC239-MRSA-III has been epidemic in China for decades. In
Hong Kong, a presence of the “South-East Asian Clade” was
reported while in Northern China, “Eurasian Clade” strains
emerge and spread (Ip et al., 2005; Chen et al., 2010, 2014a;Wang
et al., 2014).
Twenty-seven isolates originated from Hong Kong. The
majority (n= 23) belonged to the “South-East Asian Clade” with
the most common strains carrying SCC [mec III+Cd/Hg+ccrC]
(TW20) or SCC [mec III+Cd/Hg+ccrC] (Bmb9393) (nine and
seven isolates, respectively). Another isolate had a SCC [mec
III+Cd/Hg+ccrC] (TW20)-derived pseudoSCCmec element. Two
isolates belonged to the “Eurasian Clade”, likely to indicate influx
from mainland China (Wang et al., 2014) and two isolates were
assigned to the “South American/Middle Eastern Clade.”
Ecuador
In Ecuador, 2005-2013, CC239-MRSA-III was the second most
commonMRSA strain (Zurita et al., 2016) and contrarily to other
Latin American countries it is still common there (Arias et al.,
2017).
Two isolates were assigned to the “South American/Middle
Eastern Clade” being sasX/sesI negative while carrying SCC [mec
III+Cd/Hg+ccrC] (Bmb9393).
Germany/Saxony
CC239-MRSA-III is not an epidemic strain in the German state
of Saxony, or at least it has not been since 2000 and many cases
are related to foreign travel (Albrecht et al., 2011).
Eleven isolates were included into the study. Nine of them
were obtained from patients with known travel history (including
admission to foreign healthcare facilities), with nosocomial
contact to travelers, or from immigrant patients.
Five isolates were assigned to the “Eurasian Clade.” Two of
them were obtained from Macedonian and Turkish nationals,
respectively, the latter with history of hospitalization in Turkey
after trauma. A third patient with an “Eurasian Clade” isolate
appeared to have a Middle Eastern background while for
two remaining cases, no history of immigration or travel was
known. The “Greek Strain” CC239-MRSA-[III+Cd/Hg+ccrC]
(SK1585) was found in four outbreak isolates, with an index
patient who was repatriated from Greece after trauma and
emergency care (Albrecht et al., 2011). One patient with a
“South American/Middle Eastern Clade” strain had a Middle
Eastern background indeed. Finally, one isolate from a patient
of Indian background belonged to the “South-East Asian Clade”
and matched the SCCmec element of XN108.
India
CC239-MRSA-III appear to be common andwidespread in India;
and although other strains emerged meanwhile, it is, at least
regionally, still a dominant MRSA strain (D’Souza et al., 2010;
Abimanyu et al., 2012; Neetu and Murugan, 2016).
In addition to one isolate from an Indian patient in Saxony
(see above), five isolates with an Indian background were tested.
All belonged to the “South-East Asian Clade”; three matched
genome sequence of XN108 and its SCCmec subtype, and one
the Indian genome sequences of NMR07/08. A fifth isolate was
sasX/sesI positive but had a Bmb-9393-like SCCmec element.
Ireland
CC239-MRSA-III predominated in Irish hospitals in the mid-
to-late 1980s [locally known as phenotype III and antibiogram-
resistogram (AR) types 01 and 09] but has since only been
recovered sporadically or as part of localized outbreaks,
represented by AR15 and AR23 isolates recovered in 1992/93
and AR44 recovered in 2002 (Carroll et al., 1989; Rossney et al.,
1994; Shore et al., 2005). The 10 Irish ST239-MRSA-III isolates
investigated clustered into three clades and four strains.
Firstly, AR01/AR15 isolates with a distinct truncation of
mecR1 matched Harris’ “Basal/European Clade,” being identical
to sequences of Ans46 and LHH1 (from the US and Australia) as
well as to UK-EMRSA-1.
Secondly, AR09/Phenotype III isolates harbored SCC [mec
III+Cd/Hg+ccrC] (TW20), lacked sasX/sesI and matched Middle
Eastern isolates. This fits to the observation that this strain was
first brought to Ireland with an oil worker who was repatriated
from Iraq in 1985 with a subsequent major outbreak (Humphreys
et al., 1990).
AR23 could be considered a variant of the AR09 strain that
was cadD-negative.
Thirdly, AR44 harbored SCC [mec III+Cd/Hg+ccrC] (TW20)
and were sasX/sesI-positive. It has been suggested previously that
this strain was imported from Singapore (Rossney, 2003), and
indeed that this variant predominates in South-East Asia. This
outbreak was contained and did not spread beyond one unit
(Shore et al., 2005).
Kuwait
In Kuwait, CC239-MRSA-III accounted for more than 50% of
typed MRSA isolates collected in a period from 1992 to 2010
(Boswihi et al., 2016). Currently, it is still present although it
appears to be replaced by community-acquired MRSA strains
(Udo and Al-Sweih, 2017).
Fourteen Kuwaiti isolates belonged to nine different strains
and were assigned to the “Eurasian,” “South American/Middle
Eastern,” and the “South-East Asian” clades. Two isolates of
the “Eurasian Clade” harbored ACME II elements thus differing
from all other isolates of that clade. One was identical to the
Irish AR09 outbreak strain that was reported to originate from
the Middle East (see above and Humphreys et al., 1990). Three
“South-East Asian Clade” isolates were essentially identical to
TW20 and one had a Bmb9393-like SCCmec element. Six others
represented sporadic variants that were characterized by a loss of
ccrC although the usually accompanying D1GU38 was present.
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One isolate belonged to an unassigned strain that was found
mainly in the Middle East.
Pakistan
There are few studies on genotyping of MRSA from Pakistan
indicating a presence of CC239-MRSA-III in hospitals (Shabir
et al., 2010; Zafar et al., 2011; Arfat, 2013; Jamil et al., 2017) but
its absence in the community.
Five Pakistani isolates from Rawalpindi (as well as the
one previously published genome sequence from Pakistan,
NCTR #32S, GenBank JTJX) belonged to the “Eurasian Clade”,
CN79/16K-Strain. One isolate was assigned to “South-East Asian
Clade” strain with a BMB939-like SCCmec element.
Romania
CC239-MRSA-III matching the “Eurasian Clade” has been
reported to be common in Romania after 2000 (Cirlan et al., 2005;
Chen et al., 2010; Monecke et al., 2014a).
All 10 Romanian isolates included, as well as previously
published sequences, clustered into the “Eurasian Clade”, lacking
sasX/sesI but carrying mecA(BA000018), dcs as well as SCCterm02
(indicating the secondary SCC-like gene cluster inserted into
nsaB). Seven matched genome sequences 16K and CN79, and
one T0131. Two isolates had unsequenced composite SCCmec
elements including the arsenic resistance gene arsC that might
be regarded as variants of 16K/CN79- and T0131-like elements,
respectively.
Russia
After 2000, CC239-MRSA-III was found to be common in
different regions across Russia, not only in hospitals but also in
the community (Afanas’ev et al., 2010; Baranovich et al., 2010;
Yamamoto et al., 2012; Khokhlova et al., 2015; Gostev et al.,
2017). Previous reports (Afanas’ev et al., 2010; Baranovich et al.,
2010; Yamamoto et al., 2012; Gostev et al., 2017) and sequences
(16K) indicated a presence of the “Eurasian Clade” as well as
of other variants (Gostev et al., 2017). Besides, there was a
notable emergence of a distinct tst1-positive variant in the city
of Krasnoyarsk (Khokhlova et al., 2015).
The majority of Russian isolates (13/24), from Moscow, Saint
Petersburg, Kurgan and Chelyabinsk, matched the “Eurasian
Clade” and genome sequences CN79 and 16K. However, three
isolates from Saint Petersburg differed from the others in
the presence of the sea(N315)/sep allele. Four isolates from
Krasnoyarsk represent a local epidemic strain harboring tst1 and
SCC [mec III+Cd/Hg+ccrC] (Bmb9393). Isolates were identical
(although one isolate lacked presumably plasmid-borne cat,
encoding chloramphenicol resistance) to the genome sequence
of MRSA-OC3, GenBank BBKC, SAMD00019145 which also
originated from this town. The four isolates from Kurgan
and Chelyabinsk were essentially identical to ATCC 33592
(representing a clade previously known from Portugal and the
USA). One isolate from Kurgan was identical to the Taiwanese
genome sequence Z172 (SAMN02370325). One isolate from
Krasnoyarsk belonged to the “South American/Middle Eastern
Clade” and one isolate from Moscow matched the unassigned
strain that was otherwise found in the Middle East.
Saudi Arabia
Although CC239-MRSA-III is known to be present in the
Middle Eastern/Gulf region for decades (Humphreys et al., 1990),
molecular data confirming a presence of CC239-MRSA-III in
the Kingdom of Saudi Arabia have been published only in
recent years (Cirlan et al., 2005; Al-Obeid et al., 2010; Monecke
et al., 2012c; Senok et al., 2016), and differences in carriage
of ccrC, merA/B and aminoglycoside resistance genes indicated
a simultaneous existence of different variants of this strain
(Monecke et al., 2012c).
Twenty-three isolates from two different hospitals in
Riyadh were characterized. Fourteen were assigned to the
“South American/Middle Eastern Clade”, nine had SCC [mec
III+Cd/Hg+ccrC] (TW20) thus matching Irish AR09 (see above
and Humphreys et al., 1990). However, the 14 contemporary
Saudi Arabian isolates lacked splE. As isolates were obtained
from two hospitals in one city this might indicate a recent
outbreak situation. The differences in SCCmec subtypes (absence
of the mer operon resulting in SCC [mec III+Cd+ccrC] (S85)
and of mer, SCCterm01 and Q93IB7 resulting in SCC [mec
III+Cd+ccrC] (XN108)) would then only be secondary to the loss
of splE.
Another eight isolates belonged to the “South-East Asian
Clade” (being also all splE-negative) and one belonged to the
unassigned “Middle Eastern Strain.”
Trinidad & Tobago
CC239-MRSA-III has been the dominant MRSA clone in
Trinidad & Tobago at least from 2000/01 (Akpaka et al., 2007)
until 2012/2013 (Monecke et al., 2012b, 2014b).
Twenty-one isolates from Trinidad & Tobago where
characterized. All were sasX/sesI-positive. This observation
places CC239 from Trinidad & Tobago into the “South-East
Asian Clade,” rather than any other Latin American strains. The
majority (n = 14) carried SCC [mec III+Cd/Hg+ccrC] (TW20).
Four isolates harbored composite SCC elements that included
czrC, speG and additional recombinase genes ccrA/B-4. Based on
the overall patterns, the isolates could be regarded as derivatives
of SCC [mec III+Cd/Hg+ccrC] (Bmb9393).
DISCUSSION
Evolution of the SCCmec III Element
CC239 is closely linked to SCCmec III. Only a few other
lineages carry this type of SCCmec element. These include
CC5 (Kwon et al., 2006; Shittu et al., 2009; Monecke et al.,
2013b), CC398 (Nemati et al., 2008) and Staphylococcus
pseudintermedius (KM1381, GenBank AM904732.1; KM241,
GenBank AM904731). Virtually all CC239-MRSA isolates harbor
one of the many different subtypes and composite elements of
SCCmec III.
A relatively simple SCCmec III element, i.e., harboring
ccrAB3 and a class A mec complex without additional ccr genes,
heavy metal resistance markers, integrated transposons etc.
has only been observed in S. pseudintermedius (KM1381,
GenBank AM904732.1). However, it cannot safely be
assumed that SCCmec III was initially transmitted from
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S. intermedius/pseudintermedius as, to the best of our
knowledge, the earliest observation of methicillin resistance
in “S. intermedius” was reported in 1984 (Roy et al., 1984). The
most similar SCCmec III element in S. aureus can be found in
the Sanger sequenced “Eurasian Clade” strain T0131 (CP002643)
where it is only supplemented by the integration of a cadmium
resistance operon (for which cadD(R35) is used as marker herein).
The secondary set of SCC markers—ccrC, ccrAA, SCCterm02,
D1GU38, erm(A) and ant9—are integrated elsewhere in the
genomes of this lineage, distant from SCCmec and orfX. This
is not only an interesting oddity, but raises the very practical
question whether other SCC and SCCmec elements exist at
alternative chromosomal sites away from orfX. If they do, this
would have major consequences for rapid molecular MRSA tests
as these assays target the integration of SCCmec into orfX.
Another relatively simple SCCmec element can be found
in JKD6008 (CP002120.1) that, however, harbors additional
resistance genes cadD(R35), aadD and ble. Hybridization
patterns consistent with this element were observed in
most “Australian/NZ Clade” isolates and in a livestock-
associated CC5-MRSA-III isolate (see Monecke et al., 2013b
and Supplemental Table 1). KM1381, JKD6008 as well as
all “Australian/NZ Clade” and “Eurasian Clade” isolates and
sequences (except TUR1 and TUR9; Harris et al., 2010) have dcs
rather than other SCC terminal sequences andmecA(BA000018).
TUR1/TUR9 and strains of the “European” (85/2082,
AB037671.1), “South-East Asian” (TW20, FN433596.1; XN108,
CP007447; Z172, CP006838.1) and “South American/Middle
Eastern” (Bmb9393, CP005288.1) clades harbor more complex
SCCmec elements that include the cadmium resistance operon,
ccrC, ccrAA and D1GU38 as well as (often, but not always)
erm(A) and ant9, tet(K) and the mercury resistance operon.
These isolates do not have dcs and a vast majority of isolates carry
mecA(CP000046). “European Clade” sequences share the ccrC allele
(ccrC (PM1)) with the “Eurasian Clade” while “South-East Asian”
and “South American/Middle Eastern” clades have, if present, a
different ccrC allele [ccrC (TSGH17)].
The presence of the mer genes raises the question for the
benefit of mercury resistance in S. aureus/MRSA. One possible
explanation could be the past medical use of mercury (e.g., for
the treatment of syphilis, in topical agents such as merbromin,
or in dental restorative materials such as amalgam) that could
pose a selective pressure also on staphylococci colonizing the
patients in question, regardless of whether they belonged to S.
aureus or to other, coagulase-negative staphylococcal species.
This could mean that SCCmer elements predated SCCmec in the
same way as mercury use predated the clinical use of antibiotics.
If SCCmec elements evolved indeed already after the introduction
of penicillin (Harkins et al., 2017), there may have been a couple
of decades of time for the evolution and selection of composite
SCCmec/SCCmer elements.
The composite SCC [mec III+Cd/Hg+ccrC] (SK1585) element
(SK1585, KL662257.1) existed at least already in the very early
1970s (as it was found in a strain epidemic in Australia
from 1973 on; see below) and it appears to be ancestral to
many SCC elements in CC239-MRSA. All SCC elements in
“European,” “South-East Asian,” and “South American/Middle
Eastern” clades could easily be described as variants of this
particular element that have either acquired additional genes
(ACME II, speG, czrC, ccrA/B4) or lost some or several genes.
These latter genes have either no known function, are redundant
(in case of the transposon with erm(A) and ant9 as a second
copy is present elsewhere in the genome) or may no longer be of
major advantage anymore because the compounds that provide a
selective pressure are no longer frequently used (as in the case of
mercury).
When mapping the presence of subtypes of SCCmec III
on the phylogenetic trees as proposed by Harris and Castillo-
Ramírez (Harris et al., 2010; Castillo-Ramírez et al., 2012),
it becomes clear that identical subtypes can be observed in
different clades (e.g., SCC [mec III+Cd/Hg+ccrC] (TW20), SCC
[mec III+Cd/Hg+ccrC] (Bmb939)). There might be two different,
mutually non-exclusive explanations. Firstly, these elements are
subject to horizontal transfer so that SCCmec elements may be
lost, acquired and exchanged after differentiation into different
clades. Secondly, many of the SCCmec III subtypes differ in
losses or acquisitions of accessory, purposeless or redundant
genes (see above), and such events may have occurred several
times. For instance, SCC [mec III+Cd/Hg+ccrC] (TW20) and SCC
[mec III+Cd/Hg+ccrC] (Bmb9393) differ only in absence of the
redundant transposon carrying erm(A) and ant9, Q93IB7 and
SCCterm01 from the latter. It seems to be possible that this
loss (or other similar losses) may have happened multiple times,
independently from each other, to different lineages harboring
SCC [mec III+Cd/Hg+ccrC] (TW20). Among a cluster of “South
American/Middle Eastern Clade” isolates from Riyadh with a
characteristic splE deletion, we observed three SCCmec subtypes
suggesting that the losses of the mercury operon, SCCterm01 and
Q93IB7 are secondary only to the loss of this gene and that they
may spontaneously change SCC [mec III+Cd/Hg+ccrC] (TW20)
to SCC [mec III+Cd+ccrC] (S85) and SCC [mec III+Cd+ccrC]
(XN108).
An example for multiple acquisitions of one gene cluster is
the observation of ACME II in dissimilar SCC elements of rather
unrelated Australian and Kuwaiti strains. Likewise, repeated and
independent acquisitions of arc genes have already been observed
in Singapore (Hsu et al., 2015).
Evolution and Spread of the
CC239-MRSA-III Strain
Based on accumulation of SNPs and mutation rates, previous
work (Harris et al., 2010; Castillo-Ramírez et al., 2012) estimated
the emergence of CC239 to have occurred in the mid- or late
1960s. The preservation of CC239-MRSA isolated in 1971 in a
Norwegian strain collection (Smyth et al., 2010) also hints to an
emergence and early spread of this strain in the late 1960s to 1970.
When analyzing gene content, one needs to assume two
major recombination events to have occurred. One event was a
horizontal gene transfer of a large segment of CC30 DNA into a
CC8 genome (Robinson and Enright, 2004b; Holden et al., 2009).
The other was a transfer of a SCCmec III element either before
that “CC8/CC30 hybridization” into the CC30 ancestral strain,
or afterwards, into the CC239 chimeric strain. It is not clear
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which gene transfer happened first. We are not aware of a CC30-
MRSA-III strain that may have posed as a donor for the CC30
core genomic DNA and the SCCmec III element. CC239-MSSA
strains have been identified (Strain 21178, GenBank AGRN and
Luedicke et al., 2010), but they might be secondary deletion
variants that lost SCCmec III rather than methicillin-susceptible
ancestors to CC239-MRSA-III.
Our own observations also indicate that at least the “Greek
Strain” and its SCC [mec III+Cd/Hg+ccrC] (SK1585) must have
existed already in the early 1970s. There are reports of CC239
from Australia from this time and another strain, ST2249-
MRSA-III was present in Melbourne, Australia, from 1973-1979
(predating the oldest Australian isolates of CC239 by 3 years).
ST2249-MRSA-III is a chimeric strain (Nimmo et al., 2015) that
combined features of CC45, CC30, and CC8 parental strains.
The CC30- and CC8-like parts of its genome can be seen as
one continuous segment originating from a CC239 parental
strain, also including the SCC [mec III+Cd/Hg+ccrC] (SK1585)
element that is characteristic for the “Greek Strain”. This allows
two assumptions. Firstly, an importation of the “Greek Strain”
of CC239 (or of the ST2249 chimera after the hybridization
event) from Greece to Melbourne appears not improbable
given a large Greek community in this city. Secondly, if the
recombination that gave raise to ST2249-MRSA-III happened in
1973 or earlier, the “Greek Strain” CC239 and its SCCmec III
element must have existed already some time before allowing
for its emergence and spread as far as Australia. As discussed
above, the SCC [mec III+Cd/Hg+ccrC] (SK1585) element could
conveniently be regarded ancestral to many SCCmec elements
in “European,” “South-East Asian,” and “South American/Middle
Eastern” clades assuming that these elements emerged by serial
or multiple deletions, and, occasionally, by acquisitions of genes.
The other “European Clade” strains characterized by a distinct
mecR1 deletionmay have evolved in the early 1980s and spread in
a rather limited way, i.e., in Ireland, UK, Australia, New Zealand
and the USA during that decade (Ito et al., 2001; Shore et al.,
2005; Harris et al., 2010). “European Clade” strains have been in
recent years still of some relevance in Greece (and in travelers
returning from there), but otherwise they have been replaced by
other MRSA strains.
Then there is the “Eurasian Clade” (or Harris’ and Castillo-
Ramírez’ “Turkish Clade”; Harris et al., 2010; Castillo-Ramírez
et al., 2012). A comparatively low number of distinct strains
within this clade might indicate a rather recent emergence,
and earliest sequences identified (Harris et al., 2010) originate
from Eastern Europe and Turkey, from the mid-/late 1990s.
Genotyping data indicate relatedness to the “European Clade”
(Harris et al., 2010; Castillo-Ramírez et al., 2012) but the
“Eurasian Clade” and the “Australian/NZ Clade” differ from
others by harboring less complex composite SCC elements with
dcs and mecA(BA000018). Whether this indicates an independent,
second acquisition of SCCmec III cannot yet be determined. The
absence of splE and fnbB from all isolates and sequences indicate a
monophyletic, clonal origin of the entire clade. TUR1 and TUR9
differ from other strains suggesting yet another horizontal gene
transfer (possibly of a SCCmec III element from a “European”
strain into an “Eurasian” strain with interrupted nsaB). The
“Eurasian Clade” can be found in Turkey where it is frequently
isolated and widespread (Tekeli et al., 2016). Furthermore it
occurs in Eastern Europe including Macedonia (from where one
study patient came from, see paragraph on Saxony/Germany)
and, especially, Romania. In Hungary, it was common in the
1990s but it is declining since then, being replaced by other
strains (Conceicao et al., 2007). It is also present in Russia,
Pakistan and China. Recent reports from China indicate an
emergence of the “Eurasian Clade” (with spa t030) at the expense
of other CC239 strains (that is, of the “South-East Asian Clade”)
following a North South gradient. Its distribution within China
suggests import from Central Asia and/or a spill-over across the
Russian border (Chen et al., 2014b). It appears to replicate faster
than the “South-East Asian Clade” strains (Shang et al., 2016)
and this advantage appears to outweigh in direct competition
whatever advantage the presence of sasX/sesI may confer to the
“South-East Asian” strains.
As mentioned, we found isolates matching Harris’ and
Castillo-Ramírez’ “South American Clade” also in Russia
and the Middle East. This raises the question where it
emerged and to where it spread secondarily. Castillo-Ramírez
estimated “the introduction into South America to have occurred
approximately. . . in 1992 (late 1989, 1993)” (Castillo-Ramírez
et al., 2012). Since the Irish AR09/Phenotype III outbreak strain
was brought to Ireland from Iraq in 1985, and since it was
described to be similar to a strain sampled in Baghdad as early as
1984 (Humphreys et al., 1990) we assume that this clade evolved
earlier, possibly in theMiddle East fromwhere it may have spread
to India, Russia and Europe. Again, travel from India to the
Middle East and back as well as from the Middle East to Europe
might have played a role. Strains of this clade may have come to
Latin America from Europe or directly from theMiddle East, and
it became common and widespread in several Latin American
countries (Harris et al., 2010; Castillo-Ramírez et al., 2012).
Recent evidence, however, shows that this clade is declining or
disappearing, except possibly in Ecuador and Peru (Arias et al.,
2017). Many sequences of the “South American/Middle Eastern
Clade” originated from Brazil (Harris et al., 2010; Castillo-
Ramírez et al., 2012). While it is tempting to assume a link
between Portugal and Brazil, a majority of Portuguese sequences
clearly belong to a separate, geographically restricted, clade;
and the few sequences that match the “South American/Middle
Eastern Clade” might be re-imported by travelers (Harris et al.,
2010; Castillo-Ramírez et al., 2012). While it is receding in Latin
America and in India (D’Souza et al., 2010) and while it largely
disappeared from Ireland, this clade still appears to be endemic
in the Middle East and in Russia. One notable strain carrying tst1
has been endemic in the Russian town of Krasnoyarsk for several
years (first observed in 2008; Iwao et al., 2012). The presence of
the tst1 gene in CC239 is rather unique although this or a similar
strain has also been described from Iran (Havaei et al., 2013).
The “South-East Asian Clade” most likely evolved from
a “South American/Middle Eastern Clade” strain (or from a
common ancestor of both clades) by acquisition of a prophage
carrying sasX/sesI. Providing that this gene was acquired only
once, which is the most parsimonious assumption, it might be
assumed that this happened between the split of the related
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“South-East Asian,” “Portuguese,” and “South American/Middle
Eastern” lineages and the proliferation of different strains within
“South-East Asian Clade”, i.e., between ca. 1969 and 1985
based on Castillo-Ramírez’ data (Castillo-Ramírez et al., 2012).
The oldest published genome sequences originate from 1997
(CUHK_HK1997), 1998 (CHI59), 2001 (DEN907), and 2003
(TW20). The “South-East Asian Clade” spread in South-East
Asia, including India, Thailand, Malaysia, Singapore, and China.
Although it is still present in Hong Kong and in Southern
Mainland China, in Northern China “Eurasian Clade” strains
predominate nowadays (see above and Chen et al., 2014b; Shang
et al., 2016). The “South-East Asian Clade” was also occasionally
introduced to Europe, most likely by travelers (DEN907, TW20,
AR44, P32, Finland E24_98541 from the Harmony collection),
without becoming endemic there, and it also has been identified
in Canada and the USA. The presence of the “South-East
Asian Clade” and particularly of strains that appear to originate
from India and South-East Asia in Kuwait and Saudi Arabia
may easily be attributed to the large number of Indian and
South-East Asian workers in the Gulf States (Birks et al., 1988).
An interesting observation is the presence of this clade, rather
than of the “South American” one, on the Caribbean islands of
Trinidad & Tobago. A possible explanation is the Indian/South
Asian descent of a high proportion of inhabitants of Trinidad &
Tobago (ca. 38% of the total population, or 1.4 million people;
http://www.tt.undp.org/content/dam/trinidad_tobago/docs/
DemocraticGovernance/Publications/TandT_Demographic_
Report_2011.pdf). Another 35% are of African descent, but no
sufficient subtyping data for African CC239-MRSA are available.
Possibly, an importation of MRSA by visits to ancestral lands
might have played a greater role in the case of Trinidad & Tobago
than just the mere geographic proximity to Latin America.
Some of Harris’ strains from Thailand, one from Vietnam
and one from Denmark are placed into the “South-East
Asian Clade” by presence of sasX/sesI and by sequence
analysis (Harris et al., 2010; Castillo-Ramírez et al., 2012).
However, they differ from other strains of that clade in
lacking hla and in harboring dcs instead of other SCC
terminal sequences. The latter could indicate that their
SCCmec elements rather originated from a horizontal
gene transfer, maybe from the Australian/NZ lineage (see
Table 2a).
Finally, there are some isolates and sequences that do
not fit into the major clades. This includes the “Portuguese
Clade” and the “Australian/New Zealand Clade.” The former
is, according to sequence analysis (Harris et al., 2010; Castillo-
Ramírez et al., 2012), related to the “South-East Asian” and
“South American/Middle Eastern” clades. The latter was not
represented by SNP-based studies and its SCCmec element might
be more related to the one in non-CC239 strains (including
S. pseudintermedius KM1381) than to the SCCmec elements in
other CC239. We identified a cluster of Middle Eastern isolates
(including one from Libya and one from Russia) that might
constitute yet another clade. Finally there are strains such as
DS_014, UR110 and P32 that could be assigned to the major
clades but that still differ from them in particular features (such
as mecA alleles). They may have evolved by further horizontal
gene transfers. They also could be representatives of separate
lineages or clades of CC239 that may be restricted to certain
geographic regions poorly, or not at all, covered by previous
typing and sequencing work. It might be expected that there
are even more such unrecognized clades because CC239 was
common in Western Europe and the USA before modern typing
and sequencing technologies emerged, and because it is now
common in countries were such technologies are not extensively
applied.
Regarding typing technologies, NGS methods and DNA
array hybridization profiling allow assignment to clades and
strains. Arrays are currently cheaper and more convenient in a
clinical setting. NGS can achieve a higher resolution although
the definition of a “breakpoint for identity or non-identity”
(i.e., how many differences between related isolates rule out
direct transmission) still poses a challenge. This is quite a
relevant issue for practical purposes. Traditionally, a “group
of isolates that can be distinguished from other isolates of
the same genus and species by phenotypic characteristics or
genotypic characteristics or both” were regarded as a strain or
clone (Tenover et al., 1995; Dijkshoorn et al., 2000). However,
recent typing technologies achieve a level of resolution that is
sufficiently informative to differentiate dozens of variants within
one “strain” such as CC239-MRSA-III (as seen in the tables
herein). Therefore, defining “strains” may still be useful for
epidemiological purposes, but it is somewhat awkward and prone
to subjectivity. Both approaches, short read NGS methods and
microarray hybridization profiling, have difficulties with gene
duplications and translocations if potentially mobile genes are
flanked by repetitive and multi-copy sequences. Practically, this
means that both technologies are useful for typing, but for
the reconstruction of phylogenetic relationships, conventional
sequencing still is unsurpassed.
On a very practical level, the definition of clades or variants
can be useful for infection control purposes. For this pandemic
strain it was possible to define such clades and to link molecular
identifiers to geographic origins. Analyses of markers discussed
herein, regardless whether by array hybridization, multiplex
PCR, or by genome sequencing, can help assigning clinical
isolates to these clades or variants and thus help to identify the
provenance of an isolate and to discern imported from locally
acquired cases. This is relevant as this strain was able to cause
large hospital-born outbreaks upon importation with travelers
or repatriated patients, as for instance the Irish experience
(Humphreys et al., 1990; Shore et al., 2005), the TW20 outbreak
in London (Holden et al., 2009), our own observations of
the “Greek Strain” in Saxony or the spread of the “South
American/Middle Eastern” clade in Latin America or of the
“Eurasian Clade” in China showed. Based on European and
North American experience, it is tempting to assume that CC239-
MRSA-III has been side-lined by other clones or has even become
extinct. Given the increasing scale of global travel and migration,
there is still a possibility of re-importation and secondary spread.
One should keep in mind that this strain still frequently detected
in hospitals serving literally more than half of the world’s
population, i.e., China, India, South-East Asia, Turkey and the
Middle East, Romania, Russia and parts of Latin America.
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In conclusion, CC239-MRSA-III is a truly pandemic strain
that, for nearly half a century, traveled around the world,
infecting and even killing thousands of patients. This pandemic
does not originate from elusive animals hosts in jungles and
savannahs but from professionals working in the cleanest and
most hygienic environments possible, that is, hospitals and
operating theaters. Typing techniques allow following these
movements, and even pinpointing individual index patients
from whom this strain was brought into certain countries.
However, understanding of a pandemic does not automatically
results in an ability to prevent it. The very fact that an
exclusively hospital-borne pandemic can spread that far and can
last that long emphasizes an urgent need for improved hand
hygiene, mandatory screening of staff and admitted patients, and
decolonization procedures, a prudent use of antimicrobial agents
and in general far more effective infection prevention and control
measures.
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